Parsing cholesterol metabolite regulation of skin immunocytes in children to identify archetypes of human neonatal immune system
- Institution
- UNIV OF MASSACHUSETTS MED SCH WORCESTER, MA
- Principal investigator
- Joonsoo Kang
- Funding
- $792K
- Duration
- 2022–2027
Moonbase score
Still being scored
Abstract
Project Summary The Type 3 cytokine (IL-17 and IL-22) producing lymphocytes (T3L) are strategically located at the mucocutaneous barrier tissues and serve as sentinels of tissue perturbations at the interface with the outside world. Skin resident T3L develop in early life and perform dual function: Early life, they promote tissue fitness by interacting with commensals to produce tonic IL-17; and throughout life, they defend against pathogens by rapid secretion of IL-17 essential for recruitment of neutrophils to inflamed tissues and fortifying the barrier tissues. Commensal dysbiosis by low dose antibiotics during early life of animals (E15 for mice and 24-28 weeks of gestation in humans) can lead to aberrant IL-17 production and is linked to metabolic dysfunctions observed in adults, including obesity. We discovered recently that a subset of T3L in mice can sense the dietary cholesterol metabolites oxysterols to calibrate their function. These cells arise immediately after birth in mice and they are the fastest (innate-like) lymphoid responders to tissue perturbations. The recognition of oxysterols by T3L is mediated by the G protein- coupled receptor GPR183, which is expressed by all T3L in mice and humans. Gpr183 has been genetically linked to psoriasis, colitis and Type 1 diabetes susceptibility in humans. In mice, early life skin T3L subset mediates IL-17-driven psoriatic responses downstream of Toll-like Receptor signaling in keratinocytes. This function is diet-modulated and dependent on GPR183, with high cholesterol diet leading to severe diseases, and conversely, vegetarian diet dampening IL-17 production and dramatically moderating disease severity. This discovery is the first to identify potential sensors of immune modulatory dietary metabolites on lymphocytes outside the gut. In humans T3L are known to be important in psoriasis in adults, but almost nothing is known about them in early life immune system. This gap in knowledge in large part exists because there is no systematic census of T3L and their interacting partners in mucocutaneous tissues of children. This proposal will fill this gap using innovative, unbiased, complementary single cell interrogation methods to catalogue all immune cell types and states in the skin of children from infancy to adulthood, stratified multi-parametrically, including BMI, dietary habits and infection history. The skin cell atlas of children will be instrumental in establishing correlation between dietary habits and propensity towards hyper inflammatory responses, modulated by skin-resident T3L. The genome-wide information rich map will identify gene networks that govern intercellular communications and cell lineage diversification, setting a major precedent of tissue immune systems relevant for childhood immunity, and accelerate progress towards defining mechanisms of early life immune system development.
Research team
- Joonsoo KangPI
- Mehdi RashighiPI
- Andrea ReboldiPI
LOADING MOONBASE SCORE
Questions for UNIV OF MASSACHUSETTS MED SCH WORCESTER
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Univ of Massachusetts Med Sch WorcesterNot yet scored
Predictive drivers of new onset, relapse, and progression of human autoimmunity in skin
Manuel Garber · $1.2M · 2023–2028
- NIH · Univ of Massachusetts Med Sch WorcesterNot yet scored
Cholesterol metabolites coordinate skin barrier immunity centered on innate dermal gammadelta T cells programmed to produce IL-17
Joonsoo Kang · $687K · 2021–2026
- NIH · Univ of Massachusetts Med Sch Worcester68
Comprehensive Harmonization and Analysis of Case/Control Whole Genome Sequencing Data from the ALS/FTD Compute Project
John E Landers · $817K · 2023–2028